March 23, 2021 Experience Anthem $3.5 billion senior notes offering We advised the underwriters on the investment-grade debt offering
March 23, 2021 Experience Illumina $1 billion notes offering We advised the underwriters on the investment-grade debt offering
March 23, 2021 Experience MediaAlpha $370.3 million secondary offering We advised the underwriters on the SEC-registered stock offering
March 17, 2021 Experience Oncopeptides SEK 1.1 billion private placing of new shares We advised Oncopeptides on the private placement of shares
March 16, 2021 Experience Oak Street Health $920 million convertible senior notes offering We advised the initial purchasers on the Rule 144A offering
March 16, 2021 Experience Prometheus Biosciences $218.5 million IPO We advised the underwriters on the IPO and Nasdaq listing
March 15, 2021 Experience Avid Bioservices $143.8 million exchangeable senior notes offering We advised the initial purchasers on the Rule 144A offering
March 12, 2021 Experience Jounce Therapeutics $64.7 million follow-on offering We advised the underwriters on the equity offering
March 11, 2021 Experience Owens & Minor $500 million notes offering We advised the initial purchasers on the high-yield notes offering
March 9, 2021 Experience Nurix Therapeutics $160.4 million follow-on offering We advised the underwriters on the equity offering